Effect of Hand Holding on Pain and Anxiety
Launched by NECMETTIN ERBAKAN UNIVERSITY · May 12, 2024
Trial Information
Current as of February 08, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study was designed as a pre-test-post-test regular parallel group, randomized controlled experimental design. The research will be carried out in the Adult Emergency Service of the Ministry of Health of the Republic of Turkey, Konya City Hospital. Patients will be randomly divided into two groups: handholding (52) and control group (52). For the Hand Holding Group: After the patient is positioned appropriately, the patient's hand will be held by the researcher. Once the intramuscular injection is completed, the patient's hand holding will be stopped. For the Control Group: No applicati...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having vitamin B 12 1000 mcg/ml (1 ml ampoule) intramuscular treatment,
- • Being literate,
- • Are between the ages of 18-65,
- • No visual, hearing, sensory or motor loss or cognitive impairment,
- • Not using centrally or peripherally acting analgesics or sedatives,
- • There is no scar tissue, incision, lipodystrophy or signs of infection on the skin of the injection area,
- • Having a body mass index between 18.5 and 29.5,
- • Injected into the ventrogluteal area,
- • Individuals who agree to participate in the research will be included.
- Exclusion Criteria:
- • Those with chronic pain,
- • Having a psychiatric disorder,
- • Foreign nationals,
- • Patients with contact-communicable diseases will be excluded from the study.
Trial Officials
Serpil SU
Study Chair
Necmettin Erbakan University
About Necmettin Erbakan University
Necmettin Erbakan University is a prominent academic institution dedicated to advancing health sciences and research through innovative clinical trials. With a commitment to excellence in education and research, the university leverages its multidisciplinary approach to foster collaborations that enhance patient care and medical advancements. By conducting rigorous clinical studies, Necmettin Erbakan University seeks to contribute valuable insights to the medical community, ultimately improving treatment outcomes and fostering evidence-based practices in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0